Overall market sentiment has been neutral on Obalon Therapeutics Inc (OBLN) stock lately. OBLN receives a Neutral rating from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With OBLN Stock Today?
Obalon Therapeutics Inc (OBLN) stock has gained 12.01% while the S&P 500 is down -0.51% as of 10:09 AM on Monday, Feb 22. OBLN has risen $0.52 from the previous closing price of $4.33 on volume of 496,214 shares. Over the past year the S&P 500 has gained 20.48% while OBLN has risen 170.95%. OBLN lost -$2.06 per share in the over the last 12 months.
More About Obalon Therapeutics Inc
Obalon Therapeutics Inc is a medical device company that focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Its product includes Obalon Balloon System. Geographically, it derives a majority of revenue from the United States.